Browse All

Current Filters

CLEAR FILTER x

TITLE

Seasonality of Initial Attack Onset in AQP4+ NMOSD, MOGAD, and MS: Observations from a US-based Multicenter Cohort

Author:Roy, Shuvro   Gakis, Georgios   Bilodeau, Philippe-Antoine   Vishnevetsky, Anastasia   Wruble Clark, Mattia   Mahler, Joao Vitor   Said, Yana   Filippatou, Angeliki   Huang, Yishang   Wang, Yujie   Mowry, Ellen   Fitzgerald, Kathryn   Levy, Michael   Sotirchos, Elias   

Session Name:P3: Autoimmune Neurology: NMOSD/MOGAD 3  

Topic:Autoimmune Neurology  

Program Number:P3.005  

Author Institution:University of Washington, Seattle, WA  Johns Hopkins University, Baltimore, MD  Mass General Brigham, Boston, MA  

Bilateral Optic Neuritis in MOGAD: Treatment Patterns and Relapse Outcomes

Author:Alocious, Tony   Bilodeau, Philippe-Antoine   Vishnevetsky, Anastasia   Mikami, Takahisa   Anderson, Monique   Nguyen, James   Mahler, Joao Vitor   Romanow, Gabriela   Salky, Rebecca   Gillani, Rebecca   Wruble, Mattia   Levy, Michael   

Session Name:P3: Autoimmune Neurology: NMOSD/MOGAD 3  

Topic:Autoimmune Neurology  

Program Number:P3.008  

Author Institution:Imperial College London, London, United Kingdom  Massachusetts General Hospital, Boston, MA  Massachusetts General Hospital, Cambridge, MA  Mass General Hospital, Boston, MA  Mass General Brigham, Cambridge, MA  Massachusetts General Hospital/Harvard Medical School, Boston, MA  

Tocilizumab as Add-on Therapy for Severe Attacks in NMOSD and MOGAD: A Multicenter Retrospective Case Series

Author:Flanagan, Eoin P.   Vilaseca, Andreu   Bilodeau, Philippe-Antoine   Filippatou, Angeliki G.   Jiang, Mulan   Said, Yana   Chen, Haiwen   Chen, John J.   Pittock, Sean J.   Sotirchos, Elias   Levy, Michael   Kister, Ilya   

Session Name:P3: Autoimmune Neurology: NMOSD/MOGAD 3  

Topic:Autoimmune Neurology  

Program Number:P3.009  

Author Institution:Department of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine, USA, Rochester, MN  Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA  Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA, Baltimore, MD  Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, Cambridge, MA  Department of Neurology, New York University Langone Medical Centre, New York, NY, USA, New York, NY  

NMOSD Treatment Patterns in the Era of Approved Biologics: An Analysis from the SPHERES Registry

Author:Levy, Michael   Cavida, Dustin   Patterson, Kristina   Park, Jenny   Wani, Rajvi J.   Meyers, Andrea   Middaugh, Nicole   Choi, C. Jean   Gurrola, Marie   Bennett, Jeffrey   

Session Name:P3: Autoimmune Neurology: NMOSD/MOGAD 3  

Topic:Autoimmune Neurology  

Program Number:P3.011  

Author Institution:Massachusetts General Hospital/Harvard Medical School, Boston, MA  Amgen Inc., Thousand Oaks, CA  Amgen Inc. , CA  Amgen, Inc., Thousand Oaks, CA  Thermo Fisher Scientific, Waltham, MA  University of Colorado School of Medicine, Aurora, CO  

Inebilizumab for Treatment of NMOSD in a Real-world Cohort: Analysis from the SPHERES Registry

Author:Levy, Michael   Cavida, Dustin   Patterson, Kristina   Park, Jenny   Wani, Rajvi J.   Meyers, Andrea   Middaugh, Nicole   Choi, C. Jean   Gurrola, Marie   Bennett, Jeffrey   

Session Name:P3: Autoimmune Neurology: NMOSD/MOGAD 3  

Topic:Autoimmune Neurology  

Program Number:P3.012  

Author Institution:Massachusetts General Hospital/Harvard Medical School, Boston, MA  Amgen Inc., Thousand Oaks, CA  Amgen Inc. , Thousand Oaks, CA  Amgen Inc., CA  Amgen, Inc., CA  Thermo Fisher Scientific, MA  University of Colorado School of Medicine, Aurora, CO